WO2002009757A1 - Agents de prevention ou remedes contre l'obesite ou la steatose hepatique - Google Patents
Agents de prevention ou remedes contre l'obesite ou la steatose hepatique Download PDFInfo
- Publication number
- WO2002009757A1 WO2002009757A1 PCT/JP2001/006532 JP0106532W WO0209757A1 WO 2002009757 A1 WO2002009757 A1 WO 2002009757A1 JP 0106532 W JP0106532 W JP 0106532W WO 0209757 A1 WO0209757 A1 WO 0209757A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fatty liver
- obesity
- preventives
- remedies
- resorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2003-7001367A KR20030036658A (ko) | 2000-08-01 | 2001-07-30 | 비만 또는 지방간의 예방 또는 치료제 |
EP01984401A EP1306094A4 (en) | 2000-08-01 | 2001-07-30 | PROPHYLAXIS OR THERAPY FOR GASOLIBILITY OR FATIGUE |
CA002417492A CA2417492A1 (en) | 2000-08-01 | 2001-07-30 | Preventives or remedies for obesity or fatty liver |
AU2002224596A AU2002224596A1 (en) | 2000-08-01 | 2001-07-30 | Preventives or remedies for obesity or fatty liver |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000233072 | 2000-08-01 | ||
JP2000-233072 | 2000-08-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002009757A1 true WO2002009757A1 (fr) | 2002-02-07 |
Family
ID=18725654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/006532 WO2002009757A1 (fr) | 2000-08-01 | 2001-07-30 | Agents de prevention ou remedes contre l'obesite ou la steatose hepatique |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030153513A1 (ja) |
EP (2) | EP1306094A4 (ja) |
KR (1) | KR20030036658A (ja) |
CN (1) | CN1466465A (ja) |
AU (1) | AU2002224596A1 (ja) |
CA (1) | CA2417492A1 (ja) |
WO (1) | WO2002009757A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009120597A (ja) * | 2007-10-24 | 2009-06-04 | Mitsubishi Tanabe Pharma Corp | 非アルコール性脂肪肝炎の治療および/または予防薬 |
WO2009096455A1 (ja) * | 2008-01-31 | 2009-08-06 | Astellas Pharma Inc. | 脂肪性肝疾患の治療用医薬組成物 |
WO2010038796A1 (ja) * | 2008-09-30 | 2010-04-08 | 持田製薬株式会社 | C型肝炎治療剤 |
JP2015150544A (ja) * | 2014-02-19 | 2015-08-24 | 国立大学法人神戸大学 | 表面処理剤、表面処理ポリアミド逆浸透膜及びその製造方法 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006249350B2 (en) | 2003-11-19 | 2012-02-16 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
EP2428516A1 (en) * | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
WO2006128056A2 (en) * | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Novel phosphinic acid-containing thyromimetics |
WO2010062861A2 (en) * | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of obesity and diabetes |
EP2995317A1 (en) | 2010-05-26 | 2016-03-16 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
CN106176800B (zh) * | 2016-07-11 | 2019-12-06 | 韩源平 | 多聚阳离子树脂的制药应用 |
MX2019005730A (es) | 2016-11-21 | 2019-10-21 | Viking Therapeutics Inc | Metodo para tratar enfermedad de almacenamiento de glucogeno. |
EA201992703A1 (ru) | 2017-06-05 | 2020-04-15 | Вайкинг Терапьютикс, Инк. | Композиции для лечения фиброза |
KR101844184B1 (ko) | 2017-07-21 | 2018-04-02 | 씨제이헬스케어 주식회사 | 아미노알킬벤조티아제핀 유도체의 용도 |
AU2019238090A1 (en) | 2018-03-22 | 2020-10-08 | Viking Therapeutics, Inc. | Crystalline forms and methods of producing crystalline forms of a compound |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06279278A (ja) * | 1993-03-30 | 1994-10-04 | Snow Brand Milk Prod Co Ltd | 脂肪肝抑制剤 |
JPH09241206A (ja) * | 1996-03-01 | 1997-09-16 | Shionogi & Co Ltd | リグナン系化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1209138A (en) * | 1969-06-13 | 1970-10-21 | Pharma Chemie | IMPROVEMENTS IN OR RELATING TO A NEW alpha-NAPHTHOXY-ISOBUTYRIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND THERAPEUTICAL COMPOSITION CONTAINING SAME |
IT1052819B (it) * | 1975-12-12 | 1981-07-20 | Fargal Pharmasint Lab Biochim | Preparato inibitore dell assorbimento dei lipidi a base di dietilamminoetildestrano |
ATE175954T1 (de) * | 1991-10-17 | 1999-02-15 | Shionogi & Co | Verfahren zum herstellen von lignin-analoga und ausgangsprodukte dafür |
JP2001514667A (ja) * | 1997-03-17 | 2001-09-11 | タム,ユン ケー. | 肝臓脂肪症の予防のための組成物 |
-
2001
- 2001-07-30 KR KR10-2003-7001367A patent/KR20030036658A/ko not_active Application Discontinuation
- 2001-07-30 WO PCT/JP2001/006532 patent/WO2002009757A1/ja not_active Application Discontinuation
- 2001-07-30 EP EP01984401A patent/EP1306094A4/en not_active Withdrawn
- 2001-07-30 AU AU2002224596A patent/AU2002224596A1/en not_active Abandoned
- 2001-07-30 US US10/343,460 patent/US20030153513A1/en not_active Abandoned
- 2001-07-30 EP EP06024179A patent/EP1749539A2/en not_active Withdrawn
- 2001-07-30 CN CNA018162983A patent/CN1466465A/zh active Pending
- 2001-07-30 CA CA002417492A patent/CA2417492A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06279278A (ja) * | 1993-03-30 | 1994-10-04 | Snow Brand Milk Prod Co Ltd | 脂肪肝抑制剤 |
JPH09241206A (ja) * | 1996-03-01 | 1997-09-16 | Shionogi & Co Ltd | リグナン系化合物 |
Non-Patent Citations (1)
Title |
---|
MUZZARELLI RICCARDO A.A.: "Management of hypercholesterolemia and overweight by oral administration of chitosans", BIOMED. HEALTH RES., vol. 16, 1998, pages 135 - 142, XP002948373 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009120597A (ja) * | 2007-10-24 | 2009-06-04 | Mitsubishi Tanabe Pharma Corp | 非アルコール性脂肪肝炎の治療および/または予防薬 |
US8524212B2 (en) | 2007-10-24 | 2013-09-03 | Mitsubishi Tanabe Pharma Corporation | Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis |
WO2009096455A1 (ja) * | 2008-01-31 | 2009-08-06 | Astellas Pharma Inc. | 脂肪性肝疾患の治療用医薬組成物 |
JP5302900B2 (ja) * | 2008-01-31 | 2013-10-02 | アステラス製薬株式会社 | 脂肪性肝疾患の治療用医薬組成物 |
WO2010038796A1 (ja) * | 2008-09-30 | 2010-04-08 | 持田製薬株式会社 | C型肝炎治療剤 |
JPWO2010038796A1 (ja) * | 2008-09-30 | 2012-03-01 | 持田製薬株式会社 | C型肝炎治療剤 |
US9006285B2 (en) | 2008-09-30 | 2015-04-14 | Mochida Pharmaceutical Co., Ltd. | Therapeutic agent for hepatitis C |
JP2015150544A (ja) * | 2014-02-19 | 2015-08-24 | 国立大学法人神戸大学 | 表面処理剤、表面処理ポリアミド逆浸透膜及びその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20030036658A (ko) | 2003-05-09 |
CN1466465A (zh) | 2004-01-07 |
EP1306094A1 (en) | 2003-05-02 |
EP1749539A2 (en) | 2007-02-07 |
AU2002224596A1 (en) | 2002-02-13 |
CA2417492A1 (en) | 2003-01-28 |
US20030153513A1 (en) | 2003-08-14 |
EP1306094A4 (en) | 2006-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002009815A3 (en) | New pharmaceutical composition | |
WO2002009757A1 (fr) | Agents de prevention ou remedes contre l'obesite ou la steatose hepatique | |
BR9916486A (pt) | Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares | |
AUPQ127399A0 (en) | Compositions and methods for treating or preventing osteoporosis | |
AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
AUPR105400A0 (en) | Processes and compositions for water treatment | |
AU2001284690A1 (en) | Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2 | |
HUP0302922A3 (en) | Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation and pharmaceutical compositions containing them | |
WO1999005096A3 (en) | Urokinase inhibitors | |
AU2001272849A1 (en) | Composition for the treatment of osteoarthritis | |
HUP0302435A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and pharmaceutical compositions containing them | |
AU2002212739A1 (en) | Compositions for forming bone or periodontium and injections for forming bone orperiodontium | |
AU2001239052A1 (en) | Compositions for prevention and treatment of dementia | |
WO2000066104A3 (en) | Ace-2 inhibiting compounds and methods of use thereof | |
AU2001284413A1 (en) | Medicinal compositions for preventing or treating heart failure | |
ZA200109862B (en) | Amorphous nitric esters and their pharmaceutical compositions. | |
AU1530001A (en) | Inhibitor compositions | |
HUP0400801A3 (en) | Pharmaceutical compositions containing bile acid or bile salt fatty acid conjugates and their use | |
AU2003211610A1 (en) | Pharmaceutical compositions for the treatment or prevention of osteoporosis | |
AU2001232345A1 (en) | Compositions for preventing and treating digestive diseases | |
AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
AU2961199A (en) | Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection | |
AUPR809001A0 (en) | Compositions for the treatment and prevention of plant pathogens | |
WO2001030334A3 (en) | 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation | |
AU5704800A (en) | Medicinal compositions for preventing or treating diarrhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020037001367 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10343460 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001984401 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018162983 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2417492 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2001984401 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037001367 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001984401 Country of ref document: EP |